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ABSTRACT
The distribution of genes encoding different iron
acquisition systems in enteroaggregative Escheri-
chia coli (EAEC) from adults with irritable bowel
syndrome and from healthy controls was exam-
ined using a PCR assay. As many as 95.5% of
EAEC carried the chuA gene coding for a haem
receptor, and the majority of these strains also had
yersiniobactin-encoding genes. Apart from yersi-
niobactin, enterobactin was the siderophore most
frequently associated with EAEC among those
strains examined. Genes encoding aerobactin and
salmochelin siderophores were less frequent in
the group of EAEC.
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Enteroaggregative Escherichia coli (EAEC) repre-
sent the pathotype implicated in persistent and
acute diarrhoea in children and travellers in both
developing and industrialized countries. EAEC is
a heterogeneous category in terms of the pres-
ence of genes encoding virulence factors such as
toxins and adhesins [1–3]. Iron is important for
the growth of microorganisms, and most have
developed a number of diverse iron uptake
systems, e.g. siderophores and haem uptake
systems, that are considered to be important
virulence factors in the establishment of infection
or host colonization [4,5]. Among E. coli strains,
the production of four different siderophores has
been described [6]. Enterobactin (enterochelin) is
the native catecholate siderophore of most path-
ogenic and non-pathogenic E. coli strains [4].
Another catecholate siderophore, salmochelin,
produced by some E. coli isolates causing extra-
intestinal infections, is the major siderophore of
Salmonella enterica [7]. In addition to catecholate
siderophores, E. coli may synthesize the hydroxa-
mate siderophore aerobactin, which has been
associated with virulence in members of the
family Enterobacteriaceae. Many strains of E. coli,
as well as of other intestinal bacilli, have
acquired the genes of the Yersinia high-pathoge-
nicity island(HPI) encoding the mixed-type sid-
erophore yersiniobactin, which contributes to the
virulence of highly pathogenic mouse-lethal Yer-
sinia pestis, Yersinia pseudotuberculosis and Yersinia
enterocolitica 1B [8–10]. Many E. coli strains pos-
sess the ability to scavenge iron contained in host
tissue that is directly bound to iron-binding
proteins by expressing speciﬁc haem-binding
receptors [5]. EAEC, like other E. coli strains,
may produce more than one type of siderophore
and other iron utilization systems; however,
relatively few studies have examined the distri-
bution of iron acquisition systems among these
pathogens [11]. In this study, the distribution of
genes encoding ﬁve different iron acquisition
systems among EAEC isolated from adults with
irritable bowel syndrome (IBS) and healthy con-
trols was examined.
A collection of 34 EAEC strains isolated from
adult patients with IBS suffering from persistent
diarrhoea (34 isolates) and from healthy controls
(11 isolates) was taken from previous investiga-
tions [12]. All of these strains showed a pattern of
aggregative adherence to HEp-2 cells, and all but
one were positive with a primer pair complemen-
tary to the pCVD432 DNA probe speciﬁc for
EAEC in a PCR assay [13].
Primers for seven genes representing ﬁve
different iron utilization systems were used,
and their selection was based on previous
studies: irp1 and irp2, encoding yersiniobactin
[8], the yersinobactin receptor-encoding gene
fyuA [14], the fepC gene required for siderophore
transport [15], the ferric aerobactin receptor-
encoding gene iutA [16], the samochelin recep-
tor-encoding gene iroN, and the outer membrane
haem receptor-encoding gene chuA [13]. Table 1
presents the distribution of genes detected
among EAEC.
The fepC gene was detected among 27 (60%) of
the 45 EAEC isolates. Taking into consideration
the common presence of enterobactin in patho-
genic and non-pathogenic E. coli isolates, the
results obtained in this study are not surprising.
In contrast, iroN was the least frequently detected
gene in this study, as it was associated with only
seven (15.5%) isolates. The outer membrane
salmochelin receptor IroN is associated with
extra-intestinal E. coli; however, the role of IroN
in intestinal pathogens, except for invasive S. ent-
erica strains, is undetermined [7].
The iutA gene was detected in 12 (26.7%) of the
45 EAEC strains. Production of this iron utiliza-
tion system is signiﬁcantly greater among E. coli
isolates from patients with septicaemia, pyelone-
phritis and lower urinary tract infections than
among faecal isolates of healthy controls [17].
Table 1. Distribution of genes encoding iron acquisition systems among the enteroaggregative Escherichia coli (EAEC)
isolates examined in this study
EAEC strains examined
No. (%) strains showing genes
irp1 irp2 fyuA irp1 + irp2 + fyuA fepC iutA iroN chuA
Cases (n = 34) 30 (88.2) 34 (100) 24 (70.6) 24 (70.6) 21 (61.8) 8 (23.5) 5 (14.7) 32 (94.1)
Controls (n = 11) 11 (100) 11 (100) 6 (54.5) 6 (54.5) 6 (54.5) 4 (36.4) 2 (18.2) 11 (100)
Total (n = 45) 41 (91.1) 45 (100) 30 (88.2) 30 (88.2) 27 (60) 12 (26.7) 7 (15.5 43 (95.5)
n, number of strains tested.
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Okeke et al. [15], in a study of EAEC reference
strains, found an aerobactin-encoding gene in the
majority (76.2%) of strains examined, indicating
that the iron utilization system is widely distrib-
uted among EAEC strains associated with clini-
cally apparent illness.
All EAEC strains examined were positive for
irp2, whereas irp1 was present in 41 (91.1%)
isolates and fyuA in 30 (88.2%) isolates. Taken
together, 30 (88.2%) isolates that carried all three
genes were considered to be yersiniobactin-posi-
tive. The frequent occurrence of HPI genes among
EAEC isolates demonstrated in this, and similarly
in other studies, seems to be intriguing like
hypotheses that try to explain this phenomenon,
e.g. higher iron afﬁnity of yersiniobactin com-
pared with other siderophores that may confer the
growth advantage in the case of EAEC, or that HPI
genes may serve as an environmental sensing
system which, under iron depletion, inﬂuences
expression of other genes [8].
Surprisingly, chuA was most prevalent in the
EAEC isolates examined, as it was associated
with 43 (95.5%) of the 45 EAEC isolates, raising
the question of its role in these strains. The
haem utilization system associated with the
outer membrane haem receptor protein ChuA
is widely distributed among pathogenic E. coli,
and is not restricted to particular serotypes or to
strains from particular types of infection [18].
Most often, ChuA was found among highly
pathogenic bacteria such as enterohaemorrhagic
E. coli O157:H7 and Shigella dysenteriae type 1
[18,19].
This study showed that EAEC associated with
persistent diarrhoea in adults during the course of
IBS, as well as in carriage states, possessed iron
utilization systems characteristic of human patho-
gens such as Yersinia spp., Shigella dysenteriae and
enterohaemorrhagic E. coli [14,20]. However, tak-
ing into consideration that the EAEC studied
were isolated from as many as 82% of patients
with IBS, in contrast to 32% of healthy controls, it
seems that the haem receptor ChuA may serve as
an important virulence factor in IBS-associated
EAEC. The presence of efﬁcient iron utilization
systems in a polymicrobial milieu, such as that
encountered in the lumen of the human intestine,
may signiﬁcantly contribute to a growth advan-
tage of EAEC, but further studies are needed for
an understanding of the exact role of iron utili-
zation systems in EAEC.
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